Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 239

1.

Practice Variation in Triple Therapy for Patients With Both Atrial Fibrillation and Coronary Artery Disease: Insights From the ACC's National Cardiovascular Data Registry.

Wasfy JH, Kennedy KF, Chen JS, Ferris TG, Maddox TM, Yeh RW.

JACC Clin Electrophysiol. 2016 Feb;2(1):36-43. doi: 10.1016/j.jacep.2015.08.010. Epub 2015 Nov 10.

PMID:
29766851
2.

State Variation in the Use of Non-Acute Coronary Angiograms and Coronary Revascularization Procedures.

Wadhera RK, Shen C, Secemsky EA, Strom JB, Yeh RW.

JACC Cardiovasc Interv. 2018 May 14;11(9):912-913. doi: 10.1016/j.jcin.2018.03.039. No abstract available.

PMID:
29747922
3.

Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.

Tamez H, Généreux P, Yeh RW, Amin AP, Fan W, White HD, Kirtane AJ, Stone GW, Gibson CM, Harrington RA, Bhatt DL, Pinto DS; CHAMPION PHOENIX ECONOMICS Investigators.

Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27638. [Epub ahead of print]

PMID:
29726596
4.

The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry.

Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Rangan BV, Ungi I, Banerjee S, Brilakis ES.

JACC Cardiovasc Interv. 2018 Apr 26. pii: S1936-8798(18)30653-8. doi: 10.1016/j.jcin.2018.02.036. [Epub ahead of print]

PMID:
29706508
5.

30-Day Episode Payments and Heart Failure Outcomes Among Medicare Beneficiaries.

Wadhera RK, Joynt Maddox KE, Wang Y, Shen C, Yeh RW.

JACC Heart Fail. 2018 May;6(5):379-387. doi: 10.1016/j.jchf.2017.11.010. Epub 2018 Apr 11.

PMID:
29655827
6.

Academic Cardiology and Social Media: Navigating the Wisdom and Madness of the Crowd.

Yeh RW.

Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004736. doi: 10.1161/CIRCOUTCOMES.118.004736. No abstract available.

PMID:
29650720
7.

Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval.

Faridi KF, Popma JJ, Strom JB, Shen C, Choi E, Yeh RW.

Am J Cardiol. 2018 Mar 1. pii: S0002-9149(18)30252-2. doi: 10.1016/j.amjcard.2018.02.016. [Epub ahead of print]

PMID:
29627105
8.

Risk score identifies patients who will benefit from prolonged dual antiplatelet therapy.

Faridi KF, Yeh RW.

BMJ Evid Based Med. 2018 Apr;23(2):73-74. doi: 10.1136/bmjebm-2017-110822. Epub 2018 Feb 19. Review. No abstract available.

PMID:
29595135
9.

Complete vs Incomplete Revascularization During Percutaneous Coronary Intervention and Improved Survival-The Key Is Immortality.

Secemsky EA, Yeh RW.

JAMA Cardiol. 2018 Mar 28. doi: 10.1001/jamacardio.2018.0078. [Epub ahead of print] No abstract available.

PMID:
29590282
10.

Applicability of Publicly Reported Hospital Readmission Measures to Unreported Conditions and Other Patient Populations: A Cross-sectional All-Payer Study.

Butala NM, Kramer DB, Shen C, Strom JB, Kennedy KF, Wang Y, Valsdottir LR, Wasfy JH, Yeh RW.

Ann Intern Med. 2018 May 1;168(9):631-639. doi: 10.7326/M17-1492. Epub 2018 Mar 27.

PMID:
29582086
11.

Association Between 30-Day Episode Payments and Acute Myocardial Infarction Outcomes Among Medicare Beneficiaries.

Wadhera RK, Joynt Maddox KE, Wang Y, Shen C, Bhatt DL, Yeh RW.

Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004397. doi: 10.1161/CIRCOUTCOMES.117.004397.

PMID:
29530887
12.

Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings.

Jena AB, Olenski A, Blumenthal DM, Yeh RW, Goldman DP, Romley J.

J Am Heart Assoc. 2018 Mar 9;7(6). pii: e008230. doi: 10.1161/JAHA.117.008230.

13.

Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry.

Danek BA, Basir MB, O'Neill WW, Alqarqaz M, Karatasakis A, Karmpaliotis D, Jaffer FA, Yeh RW, Wyman M, Lombardi WL, Kandzari D, Lembo N, Doing A, Patel M, Mahmud E, Choi JW, Toma C, Moses JW, Kirtane A, Parikh M, Ali ZA, Garcia S, Karacsonyi J, Rangan BV, Thompson CA, Banerjee S, Brilakis ES, Alaswad K.

J Invasive Cardiol. 2018 Mar;30(3):81-87.

14.

Safety and effectiveness of zotarolimus-eluting stents for percutaneous coronary intervention: a systematic review.

Yang JX, Yeh RW.

Future Cardiol. 2018 Feb 16. doi: 10.2217/fca-2017-0091. [Epub ahead of print]

PMID:
29448810
15.

Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician.

Vidula MK, Secemsky EA, Yeh RW.

Prog Cardiovasc Dis. 2018 Jan - Feb;60(4-5):491-499. doi: 10.1016/j.pcad.2018.01.006. Epub 2018 Feb 2. Review.

PMID:
29409813
16.

National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock.

Strom JB, Zhao Y, Shen C, Chung M, Pinto DS, Popma JJ, Yeh RW.

EuroIntervention. 2018 Apr 6;13(18):e2152-e2159. doi: 10.4244/EIJ-D-17-00947.

17.

Mortality, Length of Stay, and Cost of Weekend Admissions.

Ko SQ, Strom JB, Shen C, Yeh RW.

J Hosp Med. 2018 Jan 25. doi: 10.12788/jhm.2906. [Epub ahead of print]

PMID:
29370319
18.

The Rise and Fall of Mandatory Cardiac Bundled Payments.

Wadhera RK, Yeh RW, Joynt Maddox KE.

JAMA. 2018 Jan 23;319(4):335-336. doi: 10.1001/jama.2017.19205. No abstract available.

PMID:
29327034
19.

Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis.

Elmariah S, Doros G, Benavente OR, Bhatt DL, Connolly SJ, Yusuf S, Steinhubl SR, Liu Y, Hsieh WH, Yeh RW, Mauri L.

Circ Cardiovasc Interv. 2018 Jan;11(1):e005795. doi: 10.1161/CIRCINTERVENTIONS.117.005795.

PMID:
29311290
20.

Understanding How to Improve Quality and Value for Patients With Acute Myocardial Infarction.

Wasfy JH, Yeh RW.

JAMA Cardiol. 2018 Feb 1;3(2):102-103. doi: 10.1001/jamacardio.2017.4779. No abstract available.

PMID:
29261834
21.

Should We Care About Short-Term Readmissions After Percutaneous Coronary Intervention?

Strom JB, Yeh RW.

Circ Cardiovasc Interv. 2017 Dec;10(12). pii: e006123. doi: 10.1161/CIRCINTERVENTIONS.117.006123. No abstract available.

PMID:
29246919
22.

Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project.

Hess PL, Kennedy K, Cowherd M, Virani SS, Masoudi FA, Navar AM, Yeh RW, Ho PM, Maddox TM.

Am Heart J. 2018 Jan;195:151-152. doi: 10.1016/j.ahj.2017.09.004. Epub 2017 Sep 9. No abstract available.

PMID:
29224643
23.

Readmissions After Revascularization Procedures for Peripheral Arterial Disease: A Nationwide Cohort Study.

Secemsky EA, Schermerhorn M, Carroll BJ, Kennedy KF, Shen C, Valsdottir LR, Landon B, Yeh RW.

Ann Intern Med. 2018 Jan 16;168(2):93-99. doi: 10.7326/M17-1058. Epub 2017 Dec 5.

PMID:
29204656
24.

Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry.

Tajti P, Karatasakis A, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Doing AH, Toma C, Uretsky B, Garcia S, Moses JW, Parikh M, Kirtane A, Ali ZA, Hatem R, Karacsonyi J, Danek BA, Rangan BV, Banerjee S, Ungi I, Brilakis ES.

J Invasive Cardiol. 2018 Mar;30(3):89-96. Epub 2017 Nov 15.

25.

Challenges of Assessing Therapeutic or Diagnostic Outcomes with Observational Data.

Weintraub WS, Yeh RW.

Am J Med. 2018 Feb;131(2):206-210. doi: 10.1016/j.amjmed.2017.10.027. Epub 2017 Dec 11. No abstract available.

PMID:
29103925
26.

Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry.

Valle JA, Kaltenbach LA, Bradley SM, Yeh RW, Rao SV, Gurm HS, Armstrong EJ, Messenger JC, Waldo SW.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2242-2254. doi: 10.1016/j.jcin.2017.07.020. Epub 2017 Nov 1.

PMID:
29102582
27.

High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications.

Wadhera RK, Anderson JD, Yeh RW.

Curr Heart Fail Rep. 2017 Dec;14(6):514-518. doi: 10.1007/s11897-017-0369-1. Review.

PMID:
29101664
28.

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.

Hess GP, Natarajan P, Faridi KF, Fievitz A, Valsdottir L, Yeh RW.

Circulation. 2017 Dec 5;136(23):2210-2219. doi: 10.1161/CIRCULATIONAHA.117.028430. Epub 2017 Oct 30.

PMID:
29084735
29.

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

Yeh RW, Kereiakes DJ, Steg PG, Cutlip DE, Croce KJ, Massaro JM, Mauri L; DAPT Study Investigators.

J Am Coll Cardiol. 2017 Oct 31;70(18):2213-2223. doi: 10.1016/j.jacc.2017.09.011.

PMID:
29073947
30.

Current Perspectives and Practices on Chronic Total Occlusion Percutaneous Coronary Interventions.

Patel SM, Menon RV, Burke MN, Jaffer FA, Yeh RW, Vo M, Karmpaliotis D, Azzalini L, Carlino M, Mashayekhi K, Galassi AR, Rinfret S, Ellis SG, Patel M, Rangan BV, Karatasakis A, Danek BA, Karacsonyi J, Resendes E, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2018 Feb;30(2):43-50. Epub 2017 Oct 15.

31.

Personal and Professional Characteristics of U.S. Dual-Boarded Critical Care Cardiologists in 2015.

Blumenthal DM, Mikhael B, Lawler PR, Yeh RW, Metlay JP, Dudzinski DM.

Crit Care Med. 2017 Dec;45(12):e1292-e1296. doi: 10.1097/CCM.0000000000002766.

PMID:
29023259
32.

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.

Grodzinsky A, Kosiborod M, Tang F, Jones PG, McGuire DK, Spertus JA, Beltrame JF, Jang JS, Goyal A, Butala NM, Yeh RW, Arnold SV.

Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). pii: e003553. doi: 10.1161/CIRCOUTCOMES.117.003553.

PMID:
28904076
33.

Public Reporting of Percutaneous Coronary Intervention Mortality in New York State: Are We Helping Our Patients?

Feldman DN, Yeh RW.

Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). pii: e004027. doi: 10.1161/CIRCOUTCOMES.117.004027. No abstract available.

PMID:
28893834
34.

Seasonality and Readmission after Heart Failure, Myocardial Infarction, and Pneumonia.

Butala NM, Secemsky EA, Wasfy JH, Kennedy KF, Yeh RW.

Health Serv Res. 2017 Aug 31. doi: 10.1111/1475-6773.12747. [Epub ahead of print]

PMID:
28857149
35.

Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.

Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Patel D, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW.

Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). pii: e003741. doi: 10.1161/CIRCOUTCOMES.117.003741.

PMID:
28855222
36.

Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions.

Secemsky EA, Gallagher R, Harkness J, Pomerantsev E, Gewirtz H, Jaffer FA, Yeh RW.

J Am Coll Cardiol. 2017 Aug 29;70(9):1196-1197. doi: 10.1016/j.jacc.2017.07.713. No abstract available.

PMID:
28838371
37.

Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.

Danek BA, Karatasakis A, Tajti P, Sandoval Y, Karmpaliotis D, Alaswad K, Jaffer F, Yeh RW, Kandzari DE, Lembo NJ, Patel MP, Mahmud E, Choi JW, Doing AH, Lombardi WL, Wyman RM, Toma C, Garcia S, Moses JW, Kirtane AJ, Hatem R, Ali ZA, Parikh M, Karacsonyi J, Rangan BV, Khalili H, Burke MN, Banerjee S, Brilakis ES.

Am J Cardiol. 2017 Oct 15;120(8):1285-1292. doi: 10.1016/j.amjcard.2017.07.010. Epub 2017 Jul 24.

PMID:
28826896
38.

Brachial-ankle pulse wave velocity as a marker of adverse events following non-ST-elevation myocardial infarction: a new standard in risk stratification?

Secemsky EA, Yeh RW.

Coron Artery Dis. 2017 Dec;28(8):634-635. doi: 10.1097/MCA.0000000000000548. No abstract available.

PMID:
28825931
39.

Incentivizing Transradial Access for Primary Percutaneous Coronary Intervention While Maintaining Timely Reperfusion.

Yeh RW, Kirtane AJ, Rao SV.

JAMA Cardiol. 2017 Oct 1;2(10):1057-1058. doi: 10.1001/jamacardio.2017.2348. No abstract available.

PMID:
28813548
40.

Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures).

Sapontis J, Salisbury AC, Yeh RW, Cohen DJ, Hirai T, Lombardi W, McCabe JM, Karmpaliotis D, Moses J, Nicholson WJ, Pershad A, Wyman RM, Spaedy A, Cook S, Doshi P, Federici R, Thompson CR, Marso SP, Nugent K, Gosch K, Spertus JA, Grantham JA.

JACC Cardiovasc Interv. 2017 Aug 14;10(15):1523-1534. doi: 10.1016/j.jcin.2017.05.065.

PMID:
28797429
41.

Comparison of 30-Day Readmission Rates After Hospitalization for Acute Myocardial Infarction in Men Versus Women.

O'Brien C, Valsdottir L, Wasfy JH, Strom JB, Secemsky EA, Wang Y, Yeh RW.

Am J Cardiol. 2017 Oct 1;120(7):1070-1076. doi: 10.1016/j.amjcard.2017.06.046. Epub 2017 Jul 14.

PMID:
28781023
42.

Individualizing dual antiplatelet therapy duration after percutaneous coronary intervention: from randomized control trials to personalized medicine.

Tahir UA, Yeh RW.

Expert Rev Cardiovasc Ther. 2017 Sep;15(9):681-693. doi: 10.1080/14779072.2017.1362980. Epub 2017 Aug 9. Review.

PMID:
28764572
43.

Practical Improvements for Medical Device Evaluation.

Kramer DB, Yeh RW.

JAMA. 2017 Jul 25;318(4):332-334. doi: 10.1001/jama.2017.8976. No abstract available.

PMID:
28742887
44.

Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.

Secemsky EA, Yeh RW, Mauri L; DAPT Study Investigators.

JACC Cardiovasc Interv. 2017 Jul 24;10(14):1468-1469. doi: 10.1016/j.jcin.2017.06.004. No abstract available.

PMID:
28728663
45.

Short-term rehospitalization across the spectrum of age and insurance types in the United States.

Strom JB, Kramer DB, Wang Y, Shen C, Wasfy JH, Landon BE, Wilker EH, Yeh RW.

PLoS One. 2017 Jul 10;12(7):e0180767. doi: 10.1371/journal.pone.0180767. eCollection 2017.

46.

Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy.

Partida RA, Yeh RW.

Interv Cardiol Clin. 2016 Jul;5(3):331-347. doi: 10.1016/j.iccl.2016.02.003. Epub 2016 Jun 21. Review.

PMID:
28582031
47.

Novel Method for Exchange of Impella Circulatory Assist Catheter: The "Trojan Horse" Technique.

Phillips CT, Tamez H, Tu TM, Yeh RW, Pinto DS.

J Invasive Cardiol. 2017 Jul;29(7):250-252. Epub 2017 May 15.

48.

The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.

Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Doing A, Toma C, Uretsky B, Choi J, Moses JW, Kirtane A, Parikh M, Ali Z, Lombardi WL, Kandzari DE, Lembo N, Garcia S, Wyman MR, Martinez-Parachini JR, Karatasakis A, Danek BA, Alame AJ, Resendes E, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2017 Aug;29(8):264-270. Epub 2017 May 15.

49.

Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.

Jovin IS, Shah RM, Patel DB, Rao SV, Baklanov DV, Moussa I, Kennedy KF, Secemsky EA, Yeh RW, Kontos MC, Vetrovec GW.

JACC Cardiovasc Interv. 2017 Jun 12;10(11):1102-1111. doi: 10.1016/j.jcin.2017.03.021. Epub 2017 May 17.

PMID:
28527778
50.

Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions.

Karacsonyi J, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Lombardi W, Wyman MR, Doing A, Moses JW, Kirtane A, Parikh M, Ali Z, Kandzari D, Lembo N, Garcia S, Danek BA, Karatasakis A, Resendes E, Kalsaria P, Rangan BV, Ungi I, Thompson CA, Banerjee S, Brilakis ES.

Am J Cardiol. 2017 Jul 1;120(1):40-46. doi: 10.1016/j.amjcard.2017.03.263. Epub 2017 Apr 13.

PMID:
28499595

Supplemental Content

Support Center